Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: heart disease

The State-of-the-Art of Rheumatology Symposium

Lara C. Pullen, PhD  |  June 10, 2012

Experts from across the nation describe the best clinical approaches to rheumatologic disease management.

Filed under:ConditionsGout and Crystalline ArthritisResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:AC&RAmerican College of Rheumatology (ACR)anti-inflammatoryColchicineGoutHYDROXYCHLOROQUINELupuspatient carepregnancyResearchRheumatoid arthritisrheumatologistSystemic lupus erythematosus

Three Giants of Immunology at USC

Daniel J. Wallace, MD  |  June 10, 2012

Prejudice, and how I became a rheumatologist.

Filed under:Career DevelopmentEducation & TrainingProfessional TopicsProfiles Tagged with:EducationHistoryImmunologyLupusProfilerheumatologistSystemic lupus erythematosusVasculitis

A Rheumatologic Perspective on Intimacy and Chronic Illness

Iris Zink, BSN, MSN, NP  |  May 9, 2012

Sexual dysfunction is frequently one of the first manifestations of physical illness, but is often not inquired about on routine reviews of systems.

Filed under:Axial SpondyloarthritisConditionsOsteoarthritis and Bone DisordersPatient PerspectivePractice SupportRheumatoid ArthritisSjögren’s Disease Tagged with:Ankylosing SpondylitisChronic disease managementOsteoarthritisPainpatient carePatientsRheumatoid arthritisrheumatologistsexualitySjogren's

Drug Updates: Citalopram hydrobromide, Statins, and More

Michele B. Kaufman, PharmD, BCGP  |  May 8, 2012

Information on new approvals and medication safety

Filed under:Drug Updates Tagged with:ApprovalsBiologicsdrugJAK inhibitorsjanus kinasePipelineRheumatoid arthritisSafetyStatin

Reflections on Living with Lupus, and on Treating It

Simon M. Helfgott, MD  |  April 6, 2012

There are some people whose purpose in life is to entertain. Some of us are fortunate to have them as our patients.

Filed under:ConditionsOpinionRheuminationsSpeak Out RheumSystemic Lupus Erythematosus Tagged with:cardiac tamponadedrugHelfgottHYDROXYCHLOROQUINELupusPathogenesispatient careprednisonerheumatologistSystemic lupus erythematosustherapeuticsTreatment

Rheumatoid Arthritis Drugs May Cut Cardiovascular Risk

Kathleen Louden  |  April 6, 2012

Other studies at the ACR/ARHP Annual Scientific Meeting in November examined arthritis treatment, scleroderma screening.

Filed under:Biologics/DMARDsConditionsDrug UpdatesOsteoarthritis and Bone DisordersRheumatoid ArthritisSystemic Sclerosis Tagged with:ACR/ARHP Annual MeetingcardiovasculardrugJuvenile idiopathic arthritisMethotrexateOsteoarthritisPainpatient careRheumatoid arthritisrheumatologistSclerodermaTofacitinibTreatment

The Mystery of IVIg

Eveline Wu, MD, Michael M. Frank, MD  |  March 8, 2012

Although initially given as replacement therapy for patients with primary and secondary immunodeficiency states, intravenous immunoglobulin (IVIg) has proven to be effective in the treatment of various autoimmune and inflammatory disorders. This success has led to a dramatic increase in the use of IVIg, with its use as an antiinflammatory agent now vastly surpassing its use in the treatment of immunodeficiencies. Even so, the basis for the antiinflammatory activity of IVIg remains unclear.

Filed under:ConditionsOther Rheumatic Conditions Tagged with:anti-inflammatorydrugHYDROXYCHLOROQUINEimmunodeficiencyinflammationintravenous immune globulinMethotrexatemyalgiapatient carePediatricsrheumatologistTreatment

First ARHP ‘Best of the Meeting’ Highlights Sleep Research, Osteoporosis Screening, More

Kathleen Louden  |  March 8, 2012

“The line between ACR and ARHP sessions has totally blurred,” said Donah Zack Crawford, MA, during the presentation, “Highlights from the 2011 ARHP Sessions,” here at the 2011 ACR/ARHP Annual Scientific Meeting held in Chicago in November 2011.

Filed under:Career DevelopmentConditionsEducation & TrainingMeeting ReportsOsteoarthritis and Bone DisordersProfessional TopicsResearch Rheum Tagged with:2011 ACR/ARHP Annual Scientific MeetingAC&RAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)Educationeducation and trainingObesityOsteoarthritisOsteoporosisResearchSleep

Gout – Rheumatology’s Royal Pain

Staff  |  March 8, 2012

Gout is a common rheumatic disease often characterized by swelling, redness, and intense pain in the big toe. Once thought to be an exclusive disease of the wealthy who overindulged in food and spirits, gout has become a royal pain for millions of Americans.

Filed under:ConditionsFrom the CollegeGout and Crystalline Arthritis Tagged with:AC&RAmerican College of Rheumatology (ACR)crystal arthritisDiagnostic CriteriaGoutpatient carerheumatologistTreatment

Patient Fact Sheet – Gout

Staff  |  March 8, 2012

Gout is a painful and potentially disabling form of arthritis that has been recognized since ancient times. Treatments are available to control most cases of gout, but diagnosing this disorder can be difficult, and treatment plans often have to be tailored for each person.

Filed under:ConditionsFrom the CollegeGout and Crystalline Arthritis Tagged with:AC&RAmerican College of Rheumatology (ACR)crystal arthritisDiagnostic CriteriaGoutpatient carerheumatologistTreatment

  • « Previous Page
  • 1
  • …
  • 69
  • 70
  • 71
  • 72
  • 73
  • …
  • 81
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences